ABSTRACT
Purpose
The present study aimed to develop a high-throughput screening strategy for predicting the phototoxic potential of pharmaceutical substances, using a derivatives-of-reactive-oxygen-metabolites (D-ROM) assay.
Methods
The assay conditions of the D-ROM assay were optimized with a focus on screening run time, sensitivity, solvent system, and reproducibility. The phototoxic potentials of 25 model compounds were assessed by the D-ROM assay, as well as by other screening systems for comparison, including the reactive oxygen species (ROS) assay, the DNA-photocleavage assay, and the 3T3 neutral red uptake phototoxicity test (3T3 NRU PT).
Results
Some phototoxic drugs tended to yield D-ROM when exposed to simulated sunlight (250 W/m2), whereas D-ROM generation was negligible for non-phototoxic chemicals. Compared with the ROS assay, the assay procedure for the D-ROM assay was highly simplified with a marked reduction in screening run time. Comparative experiments also demonstrated that D-ROM data were related to the outcomes of the DNA-photocleavage assay and the 3T3 NRU PT, with prediction accuracies of 76 and 72%, respectively.
Conclusion
The D-ROM assay has potential for identifying the phototoxic potential of a large number of new drugs as a 1st screening system in the early stages of drug discovery.
Similar content being viewed by others
Abbreviations
- 3T3 NRU PT:
-
3T3 neutral red uptake phototoxicity test
- 5-FU:
-
5-fluorouracil
- 8-MOP:
-
8-methoxypsoralen
- AFM:
-
atomic force microscopy
- AGE:
-
agarose gel electrophoresis
- CD:
-
circular dichroism
- DEPPD:
-
N,N-diethyl-p-phenylenediamine
- DMEM:
-
Dulbecco’s Modified Eagle Medium
- D-ROM:
-
derivatives of reactive oxygen metabolites
- EBSS:
-
Earle’s Balanced Salt Solution
- EtBr:
-
ethidium bromide
- ECVAM:
-
Europe Center for the Validation of Alternative Methods
- OC:
-
open circular
- OECD:
-
Organisation for Economic Co-operation and Development
- PIF:
-
photoirritation factor
- ROS:
-
reactive oxygen species
- SC:
-
supercoiled
- UV:
-
ultraviolet
- VIS light:
-
visible light
REFERENCES
Onoue S, Seto Y, Gandy G, Yamada S. Drug-induced phototoxicity; an early in vitro identification of phototoxic potential of new drug entities in drug discovery and development. Curr Drug Saf. 2009;4:123–36.
Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002;25:345–72.
Epstein JH, Wintroub BU. Photosensitivity due to drugs. Drugs. 1985;30:42–57.
Henry B, Foti C, Alsante K. Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule? J Photochem Photobiol B. 2009;96:57–62.
Epstein S. The Photopatch Test; Its Technique, Manifestations, And Significance. Ann Allergy. 1964;22:1–11.
Przybilla B, Schwab-Przybilla U, Ruzicka T, Ring J. Phototoxicity of non-steroidal anti-inflammatory drugs demonstrated in vitro by a photo-basophil-histamine-release test. Photodermatol. 1987;4:73–8.
Selvaag E. Evaluation of phototoxic properties of oral antidiabetics and diuretics. Photohemolysis model as a screening method for recognizing potential photosensitizing drugs. Arzneimittelforschung. 1997;47:1031–4.
Portes P, Pygmalion MJ, Popovic E, Cottin M, Mariani M. Use of human reconstituted epidermis Episkin for assessment of weak phototoxic potential of chemical compounds. Photodermatol Photoimmunol Photomed. 2002;18:96–102.
Spielmann H, Liebsch M, Doring B, Moldenhauer F. First results of an EC/COLIPA validation project of in vitro phototoxicity testing methods. Altex. 1994;11:22–31.
Sarabia Z, Hernandez D, Castell JV, van Henegouwen GM. Photoreactivity of tiaprofenic acid and suprofen using pig skin as an ex vivo model. J Photochem Photobiol B. 2000;58:32–6.
Lynch AM, Smith MD, Lane AS, Robinson SA, Kleinman MH, Kennedy-Gabb S, Wilcox P, Rees RW. An evaluation of chemical photoreactivity and the relationship to photogenotoxicity. Regul Toxicol Pharmacol. 2009; in press.
Onoue S, Tsuda Y. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm Res. 2006;23:156–64.
Onoue S, Yamauchi Y, Kojima T, Igarashi N, Tsuda Y. Analytical studies on photochemical behavior of phototoxic substances; effect of detergent additives on singlet oxygen generation. Pharm Res. 2008;25:861–8.
Onoue S, Igarashi N, Yamada S, Tsuda Y. High-throughput reactive oxygen species (ROS) assay: an enabling technology for screening the phototoxic potential of pharmaceutical substances. J Pharm Biomed Anal. 2008;46:187–93.
Onoue S, Igarashi N, Kitagawa F, Otsuka K, Tsuda Y. Capillary electrophoretic studies on the photogenotoxic potential of pharmaceutical substances. J Chromatogr A. 2008;1188:50–6.
Onoue S, Seto Y, Oishi A, Yamada S. Novel methodology for predicting photogenotoxic risk of pharmaceutical substances based on reactive oxygen species (ROS) and DNA-binding assay. J Pharm Sci. 2009;98:3647–58.
Gocke E, Albertini S, Chetelat AA, Kirchner S, Muster W. The photomutagenicity of fluoroquinolones and other drugs. Toxicol Lett. 1998;102–103:375–81.
Onoue S, Kawamura K, Igarashi N, Zhou Y, Fujikawa M, Yamada H et al. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates. J Pharm Biomed Anal. 2008;47:967–72.
Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res. 2007;631:55–61.
Salardi S, Zucchini S, Elleri D, Grossi G, Bargossi AM, Gualandi S et al. High glucose levels induce an increase in membrane antioxidants, in terms of vitamin E and coenzyme Q10, in children and adolescents with type 1 diabetes. Diab Care. 2004;27:630–1.
Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr. 2001;131:3208–11.
Alberti A, Bolognini L, Macciantelli D, Caratelli M. The radical cation of N,N-diethyl-para-phenylendiamine: a possibe indicator of oxidative stress in biological samples. Res Chem Intermed. 2000;26:253–67.
Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett. 1985;24:119–24.
Peters B, Holzhutter HG. In vitro phototoxicity testing: development and validation of a new concentration response analysis software and biostatistical analyses related to the use of various prediction models. Altern Lab Anim. 2002;30:415–32.
Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 1999;4:67–73.
Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol. 1991;54:659.
Hei TK, Liu SX, Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci USA. 1998;95:8103–7.
Schwarzenbach RP, Gschwend PM, Imboden DM. Environmental organic chemistry. New York: Wiley; 1993.
Keum YS, Kim JH, Kim YW, Kim K, Li QX. Photodegradation of diafenthiuron in water. Pest Manag Sci. 2002;58:496–502.
Epe B. Genotoxicity of singlet oxygen. Chem Biol Interact. 1991;80:239–60.
Rega MF, Reed JC, Pellecchia M. Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists. Bioorg Chem. 2007;35:113–20.
Dubakiene R, Kupriene M. Scientific problems of photosensitivity. Medicina (Kaunas). 2006;42:619–24.
Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol. 1995;33:551–73. quiz 574–6.
Allen JE. Drug-induced photosensitivity. Clin Pharm. 1993;12:580–7.
Brendler-Schwaab S, Czich A, Epe B, Gocke E, Kaina B, Muller L et al. Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutat Res. 2004;566:65–91.
Liebsch M, Spielmann H. Currently available in vitro methods used in the regulatory toxicology. Toxicol Lett. 2002;127:127–34.
EMEA Report. Committee for propriety medicinal products (CPMP). Notes for guidance on photosafety testing CPMP/SWP/398/01. http://www.emea.europa.eu/pdfs/human/swp/039801en.pdf; 2002.
Stein KR, Scheinfeld NS. Drug-induced photoallergic and phototoxic reactions. Expert Opin Drug Saf. 2007;6:431–43.
ACKNOWLEDGEMENTS
This work was supported in part by a Grant-in-Aid from the Food Safety Commission, Japan (No. 0807).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Onoue, S., Ochi, M., Gandy, G. et al. High-Throughput Screening System for Identifying Phototoxic Potential of Drug Candidates Based on Derivatives of Reactive Oxygen Metabolites. Pharm Res 27, 1610–1619 (2010). https://doi.org/10.1007/s11095-010-0161-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-010-0161-3